Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference

Nick E Ingraham; Christopher J. Tignanelli

doi:10.1097/CCE.0000000000000108

Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference

Nick E Ingraham, Christopher J. Tignanelli

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	E0108
Journal	Critical Care Explorations
Volume	2
Issue number	4
DOIs	https://doi.org/10.1097/CCE.0000000000000108 https://doi.org/10.1097/CCE.0000000000000108
State	Published - Apr 9 2020

Bibliographical note

Funding Information:
Dr. Tignanelli is a principal investigator for two randomized control trials investigating angiotensin-receptor blockers in the treatment of coronavirus disease 2019 among inpatient and outpatients. Co-investigators include Dr. Ingraham. Dr. Ingraham received funding from National Institutes of Health and National Heart, Lung, and Blood Institute (T32HL07741).

Keywords

coronavirus disease 2019
evidence-based medicine
hydroxychloroquine
misinformation
pandemic
research

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

Find It

Find It at U of M Libraries

Cite this

@article{c0d38252697f426ebec89ae7560a4c69,

title = "Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference",

keywords = "coronavirus disease 2019, evidence-based medicine, hydroxychloroquine, misinformation, pandemic, research",

author = "Ingraham, {Nick E} and Tignanelli, {Christopher J.}",

note = "Funding Information: Dr. Tignanelli is a principal investigator for two randomized control trials investigating angiotensin-receptor blockers in the treatment of coronavirus disease 2019 among inpatient and outpatients. Co-investigators include Dr. Ingraham. Dr. Ingraham received funding from National Institutes of Health and National Heart, Lung, and Blood Institute (T32HL07741). ",

year = "2020",

month = apr,

day = "9",

doi = "10.1097/CCE.0000000000000108",

language = "English (US)",

volume = "2",

pages = "E0108",

journal = "Critical Care Explorations",

issn = "2639-8028",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Fact Versus Science Fiction

T2 - Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference

AU - Ingraham, Nick E

AU - Tignanelli, Christopher J.

N1 - Funding Information: Dr. Tignanelli is a principal investigator for two randomized control trials investigating angiotensin-receptor blockers in the treatment of coronavirus disease 2019 among inpatient and outpatients. Co-investigators include Dr. Ingraham. Dr. Ingraham received funding from National Institutes of Health and National Heart, Lung, and Blood Institute (T32HL07741).

PY - 2020/4/9

Y1 - 2020/4/9

KW - coronavirus disease 2019

KW - evidence-based medicine

KW - hydroxychloroquine

KW - misinformation

KW - pandemic

KW - research

UR - http://www.scopus.com/inward/record.url?scp=85098476620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098476620&partnerID=8YFLogxK

U2 - 10.1097/CCE.0000000000000108

DO - 10.1097/CCE.0000000000000108

M3 - Comment/debate

C2 - 32426750

SN - 2639-8028

VL - 2

SP - E0108

JO - Critical Care Explorations

JF - Critical Care Explorations

IS - 4

ER -

Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Cite this